New insights into the pathogenesis and genetics of psoriatic arthritis
- PMID: 19182814
- PMCID: PMC2790861
- DOI: 10.1038/ncprheum0987
New insights into the pathogenesis and genetics of psoriatic arthritis
Abstract
Psoriasis vulgaris and psoriatic arthritis (PsA) are inter-related heritable diseases. Psoriatic skin is characterized by hyperproliferative, poorly differentiated keratinocytes and severe inflammation. Psoriatic joints are characterized by highly inflamed synovia and entheses with focal erosions of cartilage and bone. Genetic analyses have uncovered risk factors shared by both psoriasis and PsA. Predisposition to psoriasis and PsA arising from common variation is most strongly conferred by the HLA class I region. Other genetic risk factors implicate the interleukin (IL)-23 pathway and the induction and regulation of type 17 T-helper cells in the pathogenesis of both diseases. Secretion of cytokines, such as IL-22 and IL-17, could result in the hyperproliferative phenotype of keratinocytes and potentially synoviocytes, leading to a vicious cycle of cellular proliferation and inflammation in both the skin and joints. In synovial tissue, disease-related cytokines could also promote osteoclast formation, resulting in bone erosion. The next step will be to identify genetic risk factors specifically associated with PsA. Although therapies that target tumor necrosis factor are often highly successful in the treatment of both diseases, genetic findings are likely to lead to the development of treatments tailored to an individual's genetic profile.
Figures
Similar articles
-
Depressing time: Waiting, melancholia, and the psychoanalytic practice of care.In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. In: Kirtsoglou E, Simpson B, editors. The Time of Anthropology: Studies of Contemporary Chronopolitics. Abingdon: Routledge; 2020. Chapter 5. PMID: 36137063 Free Books & Documents. Review.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
Qualitative evidence synthesis informing our understanding of people's perceptions and experiences of targeted digital communication.Cochrane Database Syst Rev. 2019 Oct 23;10(10):ED000141. doi: 10.1002/14651858.ED000141. Cochrane Database Syst Rev. 2019. PMID: 31643081 Free PMC article.
-
Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750. Health Technol Assess. 2021. PMID: 34931602 Clinical Trial.
-
Valley fever under a changing climate in the United States.Environ Int. 2024 Nov;193:109066. doi: 10.1016/j.envint.2024.109066. Epub 2024 Oct 11. Environ Int. 2024. PMID: 39432997 Review.
Cited by
-
IL-6 regulates neutrophil microabscess formation in IL-17A-driven psoriasiform lesions.J Invest Dermatol. 2014 Mar;134(3):728-735. doi: 10.1038/jid.2013.404. Epub 2013 Sep 25. J Invest Dermatol. 2014. PMID: 24067382
-
Th17 and Th22 cells in psoriatic arthritis and psoriasis.Arthritis Res Ther. 2013 Sep 26;15(5):R136. doi: 10.1186/ar4317. Arthritis Res Ther. 2013. PMID: 24286492 Free PMC article.
-
Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNFα in psoriatic arthritis.Int J Clin Exp Med. 2014 Sep 15;7(9):2605-14. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25356116 Free PMC article.
-
Bioboosters in the treatment of rheumatic diseases: a comprehensive review of currently available biologics in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis.Open Access Rheumatol. 2009 Dec 4;1:163-178. doi: 10.2147/oarrr.s4490. eCollection 2009. Open Access Rheumatol. 2009. PMID: 27789989 Free PMC article. Review.
-
Obesity and risk of incident psoriatic arthritis in US women.Ann Rheum Dis. 2012 Aug;71(8):1267-72. doi: 10.1136/annrheumdis-2011-201273. Epub 2012 May 5. Ann Rheum Dis. 2012. PMID: 22562978 Free PMC article.
References
-
- Gelfand JM, et al. The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol. 2005;52:23–6. - PubMed
-
- Menter A, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58:826–50. - PubMed
-
- Zachariae H, et al. Quality of life and prevalence of arthritis reported by 5,795 members of the Nordic Psoriasis Associations. Data from the Nordic Quality of Life Study. Acta Derm Venereol. 2002;82:108–13. - PubMed
-
- Husted JA, Gladman DD, Farewell VT, Cook RJ. Health-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritis. Arthritis Rheum. 2001;45:151–8. - PubMed
-
- Han C, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33:2167–72. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous